Selvita S.A. subsidiaries sign merger plan, consolidating operations

Selvita S.A., a Polish biotech firm, announced its subsidiaries have agreed and signed a merger plan. The move consolidates its subsidiary structure, likely to streamline operations and reduce costs. Financial terms and expected synergies are undisclosed, so the market impact is modest.